ConductScience.org, home

Paper4903501

Controlled chemoprophylaxis trials in tuberculosis. A general review.

Ferebee SH. Bibl Tuberc, 1970. Cited by 372 papers, by iCite.

Cite this record

ConductScience Library. Controlled chemoprophylaxis trials in tuberculosis. A general review. Papers, record 4903501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4903501

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Controlled chemoprophylaxis trials in tuberculosis. A general review.
PubMed
Journal
Bibl Tuberc
PubMed
Year
1970
PubMed
Publication types
Clinical Trial, Journal Article, Review
PubMed
Citations, by iCite
372
iCite
Relative citation ratio, by iCite
9.89
iCite
Revised in PubMed
2021-07-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ferebee SHS H

Source PubMed

Download CSV of authors

Topics33

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
IsoniazidMajor topic
TuberculosisMajor topic
Adolescent
Adult
Age Factors
Alaska
Anemia
Child
Child, Preschool
Clinical Trials as Topic
Drug Hypersensitivity
Drug Resistance, Microbial
Epilepsy
Female
Follow-Up Studies
Greenland
Humans
Japan
Kenya
Male
Mental Processes
Middle Aged
Neoplasms
Netherlands
New York
Philippines
Placebos
Pregnancy
Tuberculin Test
Tuberculosis, Pulmonary
Tunisia
United States
United States Public Health Service

Source PubMed

Download CSV of topics

Cited by209

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 372 citations.

PMIDTitleJournalYearIn PapersSource
42638735Tuberculosis: insights into latency, treatment strategies, and the potential roles of metronidazole.Front Tuberc2023https://conductscience.org/library/papers/42638735PubMed
42625659Machine learning-based feature selection suggests circulating proteins as best at predicting and diagnosing tuberculosis in Mycobacterium tuberculosis-exposed rhesus macaques.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42625659PubMed
41642936Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study.PLoS Med2026https://conductscience.org/library/papers/41642936PubMed
41623531Long-Term Case-Finding of Latent Tuberculosis Infection Among Household Contacts to Support Tuberculosis Elimination Efforts in Indonesia.Mater Sociomed2025https://conductscience.org/library/papers/41623531PubMed
40986702The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis.Am J Respir Crit Care Med2026https://conductscience.org/library/papers/40986702PubMed
40565607Identification of Gene Expression Biomarkers Predictive of Latent Tuberculosis Infection Using Machine Learning Approaches.Genes (Basel)2025https://conductscience.org/library/papers/40565607PubMed
39909102Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.Chest2025https://conductscience.org/library/papers/39909102PubMed
39733063Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.Drugs2025https://conductscience.org/library/papers/39733063PubMed
39364056Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.Front Pharmacol2024https://conductscience.org/library/papers/39364056PubMed
39151980Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study.Lancet Glob Health2024https://conductscience.org/library/papers/39151980PubMed
39048129Overlooked, dismissed, and downplayed: reversion of Mycobacterium tuberculosis immunoreactivity.Eur Respir Rev2024https://conductscience.org/library/papers/39048129PubMed
38954723Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence.PLOS Glob Public Health2024https://conductscience.org/library/papers/38954723PubMed
38454178Outcomes for people with TB by disease severity at presentation.Int J Tuberc Lung Dis2024https://conductscience.org/library/papers/38454178PubMed
38095783Tuberculosis Preventive Treatment.Indian J Pediatr2024https://conductscience.org/library/papers/38095783PubMed
37963250Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37963250PubMed
37919487Current Epidemiology of Pediatric Tuberculosis.Indian J Pediatr2024https://conductscience.org/library/papers/37919487PubMed
37491264Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB).Trials2023https://conductscience.org/library/papers/37491264PubMed
37477042Schwalb and Houben Respond to "The Winding Road to ARTI".Am J Epidemiol2023https://conductscience.org/library/papers/37477042PubMed
36240830Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania.Lancet Glob Health2022https://conductscience.org/library/papers/36240830PubMed
36165624To Err Is Human, to Forgive Is Pharmacodynamic.Am J Respir Crit Care Med2023https://conductscience.org/library/papers/36165624PubMed

See all 209 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4903501

GET https://conductscience.org/api/papers/v1/4903501/cited_by?page=2